Remove Data breaches Remove Examples Remove Healthcare Remove Manufacturing
article thumbnail

The hidden threats facing your intellectual property

IT Governance

When we consider the damage a data breach can cause, we tend to focus on the cost of breach reporting, potential fines and loss of reputation. For life sciences and pharmaceutical companies, this includes data on the development and testing of new therapies and details of how therapies are manufactured.

article thumbnail

Mastering healthcare data governance with data lineage

IBM Big Data Hub

Understanding data governance in healthcare The need for a strong data governance framework is undeniable in any highly-regulated industry, but the healthcare industry is unique because it collects and processes massive amounts of personal data to make informed decisions about patient care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2019 end-of-year review part 1: January to June

IT Governance

More than 770 million people learned their email addresses had been made public in what would be known as the ‘Collection #1’ data breach. Sensitive data belonging to hundreds of German politicians and public figures was published online. Mumsnet disclosed a data breach affecting 4,000 people. million (£4.2

article thumbnail

Security in a World of Physically Capable Computers

Schneier on Security

The practice of patching a security vulnerability is a good example of this. This fails in low-cost devices , whose manufacturers don't have security teams to write the patches: if you want to update your DVR or webcam for security reasons, you have to throw your old one away and buy a new one.

article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

However, even organizations that do not qualify as a “business” may nonetheless need to evaluate their data sharing arrangements and partnerships with CCPA-covered entities. It will be important for a company to assess the scope of the CMIA’s application to its activities and various types of data. Is the data medical information?

Privacy 45
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

However, even organizations that do not qualify as a “business” may nonetheless need to evaluate their data sharing arrangements and partnerships with CCPA-covered entities. It will be important for a company to assess the scope of the CMIA’s application to its activities and various types of data. Is the data medical information?

Privacy 40
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

However, even organizations that do not qualify as a “business” may nonetheless need to evaluate their data sharing arrangements and partnerships with CCPA-covered entities. It will be important for a company to assess the scope of the CMIA’s application to its activities and various types of data. Is the data medical information?

Privacy 40